Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Function, Right | 1 | 2017 | 4 | 0.560 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2017 | 14 | 0.560 |
Why?
|
| Telemetry | 1 | 2017 | 8 | 0.560 |
Why?
|
| Intracranial Embolism | 1 | 2017 | 6 | 0.560 |
Why?
|
| Atrial Flutter | 1 | 2017 | 13 | 0.560 |
Why?
|
| Ambulatory Care | 1 | 2017 | 58 | 0.550 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 101 | 0.540 |
Why?
|
| Heart Atria | 1 | 2017 | 171 | 0.510 |
Why?
|
| Heart Rate | 1 | 2017 | 375 | 0.490 |
Why?
|
| Stroke | 1 | 2017 | 241 | 0.440 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 398 | 0.410 |
Why?
|
| Echocardiography | 1 | 2017 | 108 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 231 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 298 | 0.130 |
Why?
|
| Logistic Models | 1 | 2017 | 398 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 472 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2017 | 594 | 0.120 |
Why?
|
| Prognosis | 1 | 2017 | 762 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 1935 | 0.100 |
Why?
|
| Risk Factors | 1 | 2017 | 2035 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2017 | 2461 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Imidazoles | 1 | 2009 | 60 | 0.080 |
Why?
|
| Piperazines | 1 | 2009 | 45 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2008 | 18 | 0.080 |
Why?
|
| Germinal Center | 1 | 2008 | 20 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2008 | 58 | 0.070 |
Why?
|
| Aged | 1 | 2017 | 5213 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 278 | 0.070 |
Why?
|
| Middle Aged | 1 | 2017 | 6888 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 377 | 0.060 |
Why?
|
| Male | 1 | 2017 | 12997 | 0.050 |
Why?
|
| Female | 1 | 2017 | 14610 | 0.040 |
Why?
|
| Humans | 3 | 2017 | 27090 | 0.040 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2009 | 3 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2009 | 139 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1267 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2009 | 9 | 0.020 |
Why?
|
| Bortezomib | 1 | 2009 | 18 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 29 | 0.020 |
Why?
|
| Pyrazines | 1 | 2009 | 23 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 42 | 0.020 |
Why?
|
| PAX5 Transcription Factor | 1 | 2008 | 2 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 49 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2009 | 74 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2008 | 10 | 0.020 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2008 | 11 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 155 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 99 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 40 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2008 | 114 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 368 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 185 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 245 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2009 | 773 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 375 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 738 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2009 | 468 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 482 | 0.010 |
Why?
|